← FDA Medical Device Classifications

Thymidine Kinase Activity

QTE · Class II — Moderate Risk (510(k) clearance required) · Immunology · 21 CFR 866.6010

Classification

FDA Product Code
QTE
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 866.6010
Review panel
IM
Medical specialty
Immunology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N

Definition

In vitro test to measure thymidine kinase activity (TKa) to aid in monitoring disease progression of breast cancer patients.

Market data

Cleared 510(k) submissions
1
Registered establishments
1

Source

Authoritative
FDA Device Classification database
Machine
JSON-LD · Markdown